ClinicalTrials.Veeva

Menu

Dezocine for Prevention of Catheter-related Bladder Discomfort

J

Jian-jun Yang

Status and phase

Completed
Phase 4

Conditions

Catheter Related Bladder Discomfort

Treatments

Drug: Flurbiprofen Axetil
Drug: Dezocine

Study type

Interventional

Funder types

Other

Identifiers

NCT03147066
20170110

Details and patient eligibility

About

This study evaluates the efficacy of dezocine in preventing the catheter-related bladder discomfort (CRBD) in a postanesthesia care unit (PACU).

Full description

Thirty min before the end of the surgery, patients were randomly assigned to one of the two group to receive intravenous dezocine 0.1 mg/kg (Group D, n=48) or flurbiprofen axetil 1 mg/kg (Group F, n=48) . The CRBD was assessed at 0, 1, 2, and 6 h after patient's arrival in the post-anaesthesia care unit. Severity of CRBD was graded as none, mild, moderate and severe.

Enrollment

96 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult (>/=18)
  2. Male or female
  3. Patients scheduled for abdominal surgery
  4. Undergoing catheterization
  5. Subject is American Society of Anesthesiologists (ASA) physical status 1 or 2

Exclusion criteria

  1. Patient with bladder outflow obstruction
  2. Patient with overactive bladder (frequency greater than three times per night or more than eight times per 24 h)
  3. Patient with multisystemic diseases (central nervous system, cardiovascular system hepatic, psychiatric, and end-stage renal diseases)
  4. Patient with chemical substance abuse
  5. Patient with chronic pain
  6. Patient with morbid obesity
  7. Patient needs for urgent intervention

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

96 participants in 2 patient groups

Dezocine
Experimental group
Description:
0.1 mg/kg of intravenous dezocine 30 min before the end of surgery
Treatment:
Drug: Dezocine
Flurbiprofen axetil
Active Comparator group
Description:
1 mg/kg of intravenous flurbiprofen axetil 30 min before the end of surgery
Treatment:
Drug: Flurbiprofen Axetil

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems